tiprankstipranks
Yumanity Therapeutics (YMTX)
NASDAQ:YMTX

Yumanity Therapeutics (YMTX) Cash flow

642 Followers

Yumanity Therapeutics Cash Flow

YMTX's free cash flow for Q3 2022 was $-3.68M. For the 2022 fiscal year, YMTX's free cash flow was decreased by $-30.87M and operating cash flow was $-3.68M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 21Dec 20Dec 19
Operating Cash Flow
$ -25.54M$ -48.91M$ -17.94M$ -27.21M
Investing Cash Flow
$ 3.21M$ 3.09M$ 31.04M$ 33.25M
Financing Cash Flow
$ -13.67M$ -1.03M$ 55.54M$ 3.02M
Cash Flow From Discontinued Operation
----
Other Cash Adjustment Inside Changein Cash
----
End Cash Position
$ 74.16M$ 36.03M$ 82.89M$ 14.25M
Income Tax Paid Supplemental Data
----
Interest Paid Supplemental Data
$ 1.37M$ 1.30M$ 1.29M$ 910.00K
Issuance Of Capital Stock
$ 489.00K$ 1.42M$ 54.83M$ 0.00
Issuance Of Debt
$ 1.74M$ 0.00$ 1.12M$ 14.75M
Repayment Of Debt
$ -15.90M$ -2.43M$ -347.00K$ -11.72M
Free Cash Flow
$ -25.61M$ -49.05M$ -18.18M$ -27.85M
Domestic Sales
----
Foreign Sales
----
Currency in USD

Yumanity Therapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis